Caregen (CEO Yongji Jeong), a peptide-based biotechnology company, announced that it has signed a long-term supply agreement with Unify Chemical, a Thai raw materials distribution company, for the weight management functional peptide "Korglutide." The contract is worth a total of 50 billion won and has a three-year term.
Through this agreement, Caregen strengthens its position in the Southeast Asian market and secures a stable overseas sales base. In particular, it is expected to make a full-scale foray into the Thai market, where demand for weight management products is increasing due to the high obesity rate.
Coglutide, a dual-action peptide of GLP-1 and IGF-1 independently developed by Caregen, is characterized by primarily fat-fat reduction, minimal muscle loss, and excellent tolerability and safety. According to clinical results announced in July 2024, the average weight loss rate reached 10.78%, with approximately 72% of the weight loss being body fat, and muscle loss being limited to 0.27 kg (2.9%). No cases of discontinuation were reported during the clinical trial.
Unify Chemical, the company that signed the contract, is a Thai company specializing in the distribution of food and healthcare raw materials, with established quality control and research infrastructure. The company stated, "Coglutide is a competitive product compared to existing raw materials in terms of scientific evidence and efficacy," adding, "It has high potential for use not only in health functional foods but also in the active pharmaceutical ingredient (API) sector in the future."
Currently, Coglutide is undergoing raw material registration procedures with Thai health authorities, which is expected to be completed within approximately six months. Accordingly, initial shipments are expected to be available in the first quarter of 2026.
Caregen stated, “This contract is an export case of unprecedented scale even for a single product, and is a result of the company’s technological prowess and product competitiveness being recognized internationally,” and added, “We plan to continue expanding into emerging Asian markets such as Bangladesh, Pakistan, and Malaysia in the future.”
- See more related articles
You must be logged in to post a comment.